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Background. Castleman’s disease is a benign lymphoproliferative disorder. The disease may be localized or multicentric. Three
histologic variants are recognized: hyaline vascular, plasma cell, and mixed types. Case. A 20-year-old man presented with
large left axillary mass. The histologic examination of the resected mass showed follicular pattern with large nodules of mantle
cells arranged concentrically around atrophic and vascularized germinal centers. There was also some benign-appearing bone
trabeculae interspersed with lymphoid tissue. The diagnosis of Castleman’s disease, hyaline-vascular type with osseous metaplasia,
was made.
1.Introduction
Castleman’s disease (CD) is ﬁrst described by Castleman in
1956 in a mediastinal lymph node [1, 2]. It is characterized
bybenignandmassiveproliferationoflymphoidtissue[1,3].
Three histologic variants of CD are recognized; hyaline-
vascular type (75–90%), plasma cell type (10–25%) and
mixed type (1–4%) [1, 4].
The disease may be unicentric or multicentric. The
hyaline-vascular type is usually unicentric and pauci symp-
tomatic, but plasma cell type and mixed type are usually
multicentric, associated with fever, anemia, weight loss, and
skin rash with a more aggressive behavior [1, 2].
TheexactetiologyofCDisunclear,butimmunosuppres-
sion, viral infection, autoimmunity, and chronic inﬂamma-
tion are proposed to have a role in disease development [5].
Among these, there is a strong evidence of human herpes
virus-8 (HHV-8) infection as the etiologic agent of some
form of CD [1].
Herein we present a case of localized hyaline-vascular
type of CD presented as an axillary lymphadenopathy show-
ing osseous metaplasia.
2.Case
A20-year-oldmanreferredtosurgerydepartmentofFaghihi
hospital, aﬃliated to Shiraz University of medical science,
due to painless left axillary mass for 2 months duration. His
past medical history was unremarkable. On physical exam-
ination he had stable vital signs. A ﬁrm mass was palpated
at the left axillary area measuring about 8 × 7c e n t i m e t e r
(cm). There was no evidence of hepatosplenomegaly and
generalized lymphadenopathy.
Left axillary ultrasound examination showed a well-
deﬁned superﬁcial mass with area of punctate calciﬁcation
with no evidence of hemorrhage and necrosis, suggestive of
an enlarged lymph node (Figure 1).
The patient’s lab data including complete blood count
with diﬀerential and biochemical tests were within normal
limits. Chest X-ray and abdominal ultrasound were normal.
The left axillary mass was excised. On gross inspection,
there was a ﬁrm creamy brown lymph node, measuring
8 × 7 × 5cm with focal areas of white discoloration and
hard consistency (Figure 2). Histologic examination revealed
follicular pattern with large nodules of mantle cells arranged
concentrically around atrophic and vascularized germinal2 Case Reports in Medicine
Figure 1: Left axillary ultrasound shows a well-deﬁned mass with
area of punctuate calciﬁcation.
Figure 2: Enlarged axillary lymph node shows areas of ossiﬁcation.
centers (Figures 3(a) and 3(b)). There was also some benign-
appearingbonetrabeculaeinterspersedwithlymphoidtissue
(Figure 4).
The diagnosis based on histologic examination was
Castleman’s disease, hyaline-vascular type with osseous
metaplasia.
3. Discussion
CD is a benign lymphoproliferative disorder [1–6]. It is
variously named as angiofollicular hyperplasia, giant lymph
node hyperplasia, angiomatous lymphoid hyperplasia, local-
ized nodal hyperplasia, and lymphoid hamartoma [3, 5].
CD has a wide age distribution ranging from adolescence to
seven decades [1–3].
In 1972 Keller et al. [7] divided CD in three histologic
types: hyaline vascular type (75–90%), plasma cell type (10–
25%), and mixed type (1–4%) [1, 4]. The hyaline-vascular
type is characterized by small-to medium-sized follicles that
contain small blood vessels that penetrate atrophic germinal
centers [1, 8]. The mantle zone lymphocytes arrange in
concentric layering at the periphery of follicles resulting in
an onion-skin appearance [9]. The interfollicular stroma is
also vascular [1]. While plasma cell type is characterized by
proliferation of plasma cells in interfollicular tissue [1, 9].
According to clinical presentation CD may be unicentric
or multicentric [1–6, 9, 10]. The unicentric form is usually
of hyaline-vascular type, pauci symptomatic with favorable
prognosis and commonly involves the mediastinum [3, 4].
Most cases of multicentric CD are of plasma cell type,
(a)
(b)
Figure 3:Lymphnodeshowslargenodulesofmantlecellsarranged
concentrically around atrophic and vascularized germinal centers,
hematoxylin, and eosin, ×100 and ×400.
Figure 4: Benign-Appearing bone trabeculae interspersed with
lymphoid tissue, hematoxylin, and eosin, ×400.
associated with anemia, fever, hyperglobulinemia, hypoalbu-
minemia, and increased erythrocyte sedimentation rate [1–
4, 9]. Another rare new histologic variant of multicentric
CD is plasmablastic type which runs an aggressive course
with higher incidence of progression to lymphoma or Kaposi
sarcoma [5, 6].
The etiology of CD is unclear. There is a strong evidence
of HHV-8 participation in development of multicentric CD
[1, 6]. It is hypothesized that HHV-8 via production of
Interleukin 6 (IL-6) is responsible for lymphoplasmacytic
and vascular proliferation, and use of blocking antibody
against IL-6 receptor may result in symptom resolution [1].Case Reports in Medicine 3
In our case osseous metaplasia was observed in a lymph
node involved by hyaline-vascular type of CD. Among
hematologic malignancies, amyloid-producing dyscrasia and
diﬀuse large B-cell lymphoma were reported to produce
heterotopic bones [10]. Two theories for this phenomenon
are proposed: (i) tumor cells directly diﬀerentiate into os-
teoblasts, (ii) tumor cells secrete substances which induce
osteoblastic diﬀerentiation in adjacent mesenchymal cells.
One of these suggested substances that induce osseous
metaplasia in epithelial tumors is bone morphogenic protein
(BMP) [10]. BMPs are members of transforming growth
factor β (TGF-β) which stimulates diﬀerentiation of mes-
enchymal cells to osteoblasts through binding to appropriate
receptor [11]. Bull et al. [12] demonstrated that HHV-8
will downregulate BMP-4 (an osteogenic factor), so osseous
metaplasia in CD may be produced by other substances. IL-6
is may be the responsible factor. Although this interleukin
is considered as a bone resorption factor, [13, 14]i tm a y
play a role in bone formation and osteoblast proliferation,
too [10, 13] .A l s oa m y l o i dd e p o s i tm a yb es e e ni nC D[ 9],
and this could be site for osseous metaplasia, but no amyloid
deposit was seen in our case.
The diﬀerential diagnosis of CD is non-Hodgkin’s lym-
phoma (follicular, mantle cell, and marginal zone B cell
lymphoma), Hodgkin’s lymphoma [8], and a variety of
reactive lymphadenopathies such as rheumatoid arthritis,
Sjogren, HIV, and drug sensitivity [6]. Unicentric CD is
cured by surgical resection, but the course of multicentric
CD is chronic, requiring continuous therapy and it may
progress to malignant lesions such as lymphoma, plasma cell
dyscrasia, or Kapos’ i sarcoma [6, 9].
4. Conclusion
To our knowledge this is the ﬁrst case of CD with osseous
metaplasia although the exact osteogenic substance is not
clear.
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